NHERF1 and carcinoma: As a significant decrease between Stage 2 and 3 cancer was observed (p = 0.021), it is also possible that EBP50 expression is altered with carcinoma stage, although significant differences were not seen when Stages 2 and 3 were compared to Stage 4.